Table 1.
Characteristics of the 357 hips identified from the literature.
| Authors | Year | Treatment | No. of patients (hips) | Age (mean) | Follow-up (months) |
|---|---|---|---|---|---|
| Case/Control | Case/Control | Case/Control | |||
| Sun et al. | 2008 | BMSC | 45(58)/13(17) | 37.5/37.3 | 12/12 |
| Yamasaki et al | 2010 | BMMC+IP-CHA | 22(30)/8(9) | 41/49 | 29/31 |
| Chang et al | 2010 | BMSC | 4(8)/4(8) | -/- | 23.5/23.5 |
| Gangji et al. | 2011 | BMSC | 13/11 | 42.2/45.7 | 60/60 |
| Zhao et al. | 2012 | BMSC | 50(53)/43(44) | 32.7/33.8 | 60/60 |
| Sen et al. | 2012 | BMMC | 20(26)/20(25) | -/- | 24/24 |
| Liu et al. | 2013 | BMMC+NH/PA | 17(28)/17(27) | 38.0/38.1 | 26.7/24.9 |
Note: BMSC: bone marrow stem cells, BMMC: bone marrow mononuclear stem cells, IP-CHA, NH/PA: both are implant materials.